250 related articles for article (PubMed ID: 28268799)
21. Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study.
Wu H; Yang L; Liu H; Zhou D; Chen D; Zheng X; Yang H; Li C; Chang J; Wu A; Wang Z; Ren N; Lv S; Liu Y; Jia M; Lu J; Liu H; Sun G; Liu Z; Liu J; Chen L
CNS Neurosci Ther; 2021 Dec; 27(12):1587-1604. PubMed ID: 34710276
[TBL] [Abstract][Full Text] [Related]
22. Tumor treating fields: a new standard treatment for glioblastoma?
Taillibert S; Le Rhun E; Chamberlain MC
Curr Opin Neurol; 2015 Dec; 28(6):659-64. PubMed ID: 26551239
[TBL] [Abstract][Full Text] [Related]
23. Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations.
Korshoej AR; Hansen FL; Mikic N; von Oettingen G; Sørensen JCH; Thielscher A
PLoS One; 2018; 13(8):e0201957. PubMed ID: 30133493
[TBL] [Abstract][Full Text] [Related]
24. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
Kesari S; Ram Z;
CNS Oncol; 2017 Jul; 6(3):185-193. PubMed ID: 28399638
[TBL] [Abstract][Full Text] [Related]
25. Tumor Treating Fields Technology: Alternating Electric Field Therapy for the Treatment of Solid Tumors.
Benson L
Semin Oncol Nurs; 2018 May; 34(2):137-150. PubMed ID: 29631935
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns.
Glas M; Ballo MT; Bomzon Z; Urman N; Levi S; Lavy-Shahaf G; Jeyapalan S; Sio TT; DeRose PM; Misch M; Taillibert S; Ram Z; Hottinger AF; Easaw J; Kim CY; Mohan S; Stupp R
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1269-1278. PubMed ID: 34963556
[TBL] [Abstract][Full Text] [Related]
27. A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians.
Kumthekar P; Lyleroehr M; Lacson L; Lukas RV; Dixit K; Stupp R; Kruser T; Raizer J; Hou A; Sachdev S; Schwartz M; Pa JB; Lezon R; Schmidt K; Amidei C; Kaiser K
BMC Cancer; 2024 Apr; 24(1):527. PubMed ID: 38664630
[TBL] [Abstract][Full Text] [Related]
28. Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.
Jones AB; Schanel TL; Rigsby MR; Griguer CE; McFarland BC; Anderson JC; Willey CD; Hjelmeland AB
Cells; 2023 Aug; 12(17):. PubMed ID: 37681903
[TBL] [Abstract][Full Text] [Related]
29. Direct-Current Electric Field Distribution in the Brain for Tumor Treating Field Applications: A Simulation Study.
Sun YS
Comput Math Methods Med; 2018; 2018():3829768. PubMed ID: 29681995
[TBL] [Abstract][Full Text] [Related]
30. Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial.
Ballo MT; Urman N; Lavy-Shahaf G; Grewal J; Bomzon Z; Toms S
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1106-1113. PubMed ID: 31026557
[TBL] [Abstract][Full Text] [Related]
31. Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma.
Xu S; Luo C; Chen D; Tang L; Chen L; Liu Z
Cell Death Dis; 2022 Aug; 13(8):721. PubMed ID: 35982032
[TBL] [Abstract][Full Text] [Related]
32. A computational study of the relation between the power density in the tumor and the maximum temperature in the scalp during Tumor Treating Fields (TTFields) therapy.
Gentilal N; Naveh A; Marciano T; Bomzon Z; Telepinsky Y; Wasserman Y; Miranda PC
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():4192-4195. PubMed ID: 34892148
[TBL] [Abstract][Full Text] [Related]
33.
Blatt R; Davidi S; Munster M; Shteingauz A; Cahal S; Zeidan A; Marciano T; Bomzon Z; Haber A; Giladi M; Weinberg U; Kinzel A; Palti Y
Front Oncol; 2021; 11():670809. PubMed ID: 34249709
[TBL] [Abstract][Full Text] [Related]
34. Skull defect increases the tumor treating fields strength without detrimental thermogenic effect: A computational simulating research.
Jin T; Dou Z; Zhao Y; Jiang B; Xu J; Zhang B; Wei B; Dong F; Zhang J; Sun C
Cancer Med; 2023 Jan; 12(2):1461-1470. PubMed ID: 35861406
[TBL] [Abstract][Full Text] [Related]
35. Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma.
Lok E; San P; Hua V; Phung M; Wong ET
Cancer Med; 2017 Jun; 6(6):1286-1300. PubMed ID: 28544575
[TBL] [Abstract][Full Text] [Related]
36. Modeling Tumor Treating fields (TTFields) application within a realistic human head model.
Wenger C; Salvador R; Basser PJ; Miranda PC
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2555-8. PubMed ID: 26736813
[TBL] [Abstract][Full Text] [Related]
37. The Mechanisms of Action of Tumor Treating Fields.
Moser JC; Salvador E; Deniz K; Swanson K; Tuszynski J; Carlson KW; Karanam NK; Patel CB; Story M; Lou E; Hagemann C
Cancer Res; 2022 Oct; 82(20):3650-3658. PubMed ID: 35839284
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Compatibility of Electric Tumor Treating Fields with Key Anti-tumoral T-Cell Functions.
Simchony H; Diamant D; Ram Z; Volovitz I
Isr Med Assoc J; 2019 Jul; 21(7):503. PubMed ID: 31507132
[TBL] [Abstract][Full Text] [Related]
39. Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors.
Branter J; Estevez-Cebrero M; Diksin M; Griffin M; Castellanos-Uribe M; May S; Rahman R; Grundy R; Basu S; Smith S
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216098
[TBL] [Abstract][Full Text] [Related]
40. Tumor treating fields: a novel treatment modality and its use in brain tumors.
Hottinger AF; Pacheco P; Stupp R
Neuro Oncol; 2016 Oct; 18(10):1338-49. PubMed ID: 27664860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
